Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma

Digestive and Liver Disease

Volumn 47, Issue 3, 2015, Pages 242-248

  Iezzi, Roberto ^a   Pompili, Maurizio ^a   La Torre, Michele Fabio ^a   Campanale, Maria Chiara ^a   Montagna, Martina ^a   Saviano, Antonio ^a   Cesario, Valentina ^a   Siciliano, Massimo ^a   Annicchiarico, Eleonora ^a   Agnes, Salvatore ^a   Giuliante, Felice ^a   Grieco, Antonio ^a   Rapaccini, Gian Lodovico ^a   De Gaetano, Anna Maria ^a   Gasbarrini, Antonio ^a   Bonomo, Lorenzo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Ablation; Chemoembolization; Combined therapy; HCC; RFA

Indexed keywords

DOXORUBICIN; EPIRUBICIN; SORAFENIB;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; MALE; OVERALL SURVIVAL; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; TREATMENT RESPONSE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; LIVER NEOPLASMS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84924029248     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.12.007     Document Type: Article

References (24)

1. Santi V., Buccione D., Di Micoli A., et al. The changing scenario of hepatocellular carcinoma over the last two decades in Italy. Journal of Hepatology 2012, 56:397-405.
2. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917.
3. Piscaglia F., Cucchetti A., Bolondi L. "Survival benefit": the final destination, with still a long way to go. Digestive and Liver Disease 2010, 49:608-610.
4. Bruix J., Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002, 35:519-524.
5. Torzilli G., Belghiti J., Kokudo N., et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West Study Group. Annals of Surgery 2013, 257:929-937.
6. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: update review in 2010. Oncology 2010, 78:113-124.
7. Pompili M., Francica G., Ponziani F.R., et al. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World Journal of Gastroenterology 2013, 19:7515-7530.
8. Llovet J.M., Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003, 37:429-442.
9. Lammer J., Malagari K., Vogl T., et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovascular and Interventional Radiology 2010, 33:41-52.
10. Malagari K., Pomoni M., Moschouris H., et al. Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis. Cardiovascular and Interventional Radiology 2012, 35:1119-1128.
11. Grosso M., Vignali C., Quaretti P., et al. Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovascular and Interventional Radiology 2008, 31:1141-1149.
12. Burrel M., Reig M., Forner A., et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design. Journal of Hepatology 2012, 56:1330-1335.
13. Yamakado K., Nakatsuka A., Takaki H., et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008, 247:260-266.
14. Veltri A., Moretto P., Doriguzzi A., et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). European Radiology 2006, 16:661-669.
15. Takaki H., Yamakado K., Uraki J., et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. Journal of Vascular and Interventional Radiology 2009, 20:217-224.
16. Bruix J., Sherman M., Practice Guidelines Committee, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
17. Goldberg S.N., Grassi C.J., Cardella J.F., et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Journal of Vascular and Interventional Radiology 2009, 20:377-390.
18. Lencioni R., Llovet J.M. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Seminars in Liver Disease 2010, 30:52-60.
19. Rossi S., Garbagnati F., Lencioni R., et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000, 217:119-126.
20. Yamasaki T., Kurokawa F., Shirahashi H., et al. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Cancer 2002, 95:2353-2360.
21. Ahrar K., Newman R.A., Pang J., et al. Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. Journal of Vascular and Interventional Radiology 2004, 15:901-905.
22. Iezzi R., Cesario V., Siciliani L., et al. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE). La Radiologia medica 2013, 118:555-569.
23. Iezzi R., Pompili M., Gasbarrini A., et al. Sequential or combined treatment? That is the question. Radiology 2014, 272:612-613.
24. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Journal of Hepatology 2012, 56:908-943.